
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6296405
[patent_doc_number] => 20100240645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'COMBINATION OF CHECKPONIT KINASE (CHK) AND TELANGIECTASIA MUTATED (ATM) INHIBITORS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/601332
[patent_app_country] => US
[patent_app_date] => 2008-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9452
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240645.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601332
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601332 | COMBINATION OF CHECKPONIT KINASE (CHK) AND TELANGIECTASIA MUTATED (ATM) INHIBITORS FOR THE TREATMENT OF CANCER | May 22, 2008 | Abandoned |
Array
(
[id] => 7966363
[patent_doc_number] => 07939529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/154056
[patent_app_country] => US
[patent_app_date] => 2008-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 33443
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939529.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154056 | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof | May 18, 2008 | Issued |
Array
(
[id] => 4720068
[patent_doc_number] => 20080242591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'METHODS OF REDUCING ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/118373
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8007
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242591.pdf
[firstpage_image] =>[orig_patent_app_number] => 12118373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/118373 | Methods of reducing angiogenesis | May 8, 2008 | Issued |
Array
(
[id] => 74341
[patent_doc_number] => 07749993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Method for treating severe heart failure and medicament therefor'
[patent_app_type] => utility
[patent_app_number] => 12/149578
[patent_app_country] => US
[patent_app_date] => 2008-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5852
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749993.pdf
[firstpage_image] =>[orig_patent_app_number] => 12149578
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/149578 | Method for treating severe heart failure and medicament therefor | May 4, 2008 | Issued |
Array
(
[id] => 4823152
[patent_doc_number] => 20080227755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'METHOD OF ADMINISTERING BISPHOSPHONATES'
[patent_app_type] => utility
[patent_app_number] => 12/107540
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4639
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227755.pdf
[firstpage_image] =>[orig_patent_app_number] => 12107540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/107540 | METHOD OF ADMINISTERING BISPHOSPHONATES | Apr 21, 2008 | Abandoned |
Array
(
[id] => 5521965
[patent_doc_number] => 20090029946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Aqueous oral solution of bisphosphonic acid'
[patent_app_type] => utility
[patent_app_number] => 12/082796
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1820
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029946.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082796
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082796 | Aqueous oral solution of bisphosphonic acid | Apr 13, 2008 | Issued |
Array
(
[id] => 6486683
[patent_doc_number] => 20100285516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'CALCIUM FLUX AS A PHARMACOEFFICACY BIOMARKER FOR INHIBITORS OF HISTONE DEACETYLASE'
[patent_app_type] => utility
[patent_app_number] => 12/595802
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 11538
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285516.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595802 | CALCIUM FLUX AS A PHARMACOEFFICACY BIOMARKER FOR INHIBITORS OF HISTONE DEACETYLASE | Apr 10, 2008 | Abandoned |
Array
(
[id] => 4493743
[patent_doc_number] => 07956092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Non-toxic insecticide'
[patent_app_type] => utility
[patent_app_number] => 12/101655
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3698
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101655 | Non-toxic insecticide | Apr 10, 2008 | Issued |
Array
(
[id] => 185299
[patent_doc_number] => 07649022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-19
[patent_title] => 'Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/058613
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26474
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/649/07649022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12058613
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/058613 | Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use | Mar 27, 2008 | Issued |
Array
(
[id] => 5417022
[patent_doc_number] => 20090042909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'METHOD OF TREATING DERMATOLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/057649
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19999
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042909.pdf
[firstpage_image] =>[orig_patent_app_number] => 12057649
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/057649 | Method of treating dermatological disorders | Mar 27, 2008 | Issued |
Array
(
[id] => 8410374
[patent_doc_number] => 08273771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Ischemic disorder or disease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/594130
[patent_app_country] => US
[patent_app_date] => 2008-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8946
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594130
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594130 | Ischemic disorder or disease inhibitors | Mar 24, 2008 | Issued |
Array
(
[id] => 141355
[patent_doc_number] => 07691416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Methods of treating vascular disease'
[patent_app_type] => utility
[patent_app_number] => 12/050826
[patent_app_country] => US
[patent_app_date] => 2008-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 57
[patent_no_of_words] => 16593
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691416.pdf
[firstpage_image] =>[orig_patent_app_number] => 12050826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/050826 | Methods of treating vascular disease | Mar 17, 2008 | Issued |
Array
(
[id] => 4599953
[patent_doc_number] => 07977382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => 'Therapeutic bio platinum complex'
[patent_app_type] => utility
[patent_app_number] => 12/076005
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3033
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977382.pdf
[firstpage_image] =>[orig_patent_app_number] => 12076005
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/076005 | Therapeutic bio platinum complex | Mar 11, 2008 | Issued |
Array
(
[id] => 8386246
[patent_doc_number] => 08263643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Polyphenol compounds with modulating neurotransmitter release'
[patent_app_type] => utility
[patent_app_number] => 12/677281
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5671
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12677281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677281 | Polyphenol compounds with modulating neurotransmitter release | Mar 11, 2008 | Issued |
Array
(
[id] => 4960595
[patent_doc_number] => 20080275020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'PHARMACEUTICAL FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/047223
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5231
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275020.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047223
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047223 | PHARMACEUTICAL FORMULATION | Mar 11, 2008 | Abandoned |
Array
(
[id] => 5361617
[patent_doc_number] => 20090036411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES'
[patent_app_type] => utility
[patent_app_number] => 12/044716
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10139
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036411.pdf
[firstpage_image] =>[orig_patent_app_number] => 12044716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/044716 | MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES | Mar 6, 2008 | Abandoned |
Array
(
[id] => 5422971
[patent_doc_number] => 20090149426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'PROCESS FOR SYNTHESIZING SILVER-SILICA PARTICLES AND APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/041372
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14760
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149426.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041372 | Process for synthesizing silver-silica particles and applications | Mar 2, 2008 | Issued |
Array
(
[id] => 4508212
[patent_doc_number] => 07915290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-29
[patent_title] => 'Argatroban formulations and methods for making and using same'
[patent_app_type] => utility
[patent_app_number] => 12/040756
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4519
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/915/07915290.pdf
[firstpage_image] =>[orig_patent_app_number] => 12040756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040756 | Argatroban formulations and methods for making and using same | Feb 28, 2008 | Issued |
Array
(
[id] => 4698988
[patent_doc_number] => 20080221172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => ' Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection'
[patent_app_type] => utility
[patent_app_number] => 12/038381
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5552
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12038381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/038381 | Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection | Feb 26, 2008 | Issued |
Array
(
[id] => 6196658
[patent_doc_number] => 20110028416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH COMPRISING EXTRACTS OF FOR EXAMPLE ROSEMARY OR CARAWAY'
[patent_app_type] => utility
[patent_app_number] => 12/919157
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6174
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028416.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919157
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919157 | Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway | Feb 24, 2008 | Issued |